As you know, every Wednesday in my Safety Net column, I typically review the dividend safety of a company that’s been requested by Wealthy Retirement readers. Safety Net is the most popular column in Wealthy Retirement, and we’ve...
− FROM THE DESK OF CHIEF INCOMESTRATEGIST MARC LICHTENFELD −
Before we get to this week’s Safety Net, I’d like to briefly address the presidential election and some other upcoming news.
The market ripped higher this morning due to Donald...
You’ve probably heard enough about the election, so I’m not going to comment any more on what it may mean for your portfolio or anything like that. You can read what I wrote about it here if –...
Canopy Growth (Nasdaq: CGC) is one of the world’s largest cannabis companies, but lately, it’s been grabbing headlines for all the wrong reasons.
The Canadian producer and distributor of cannabis products has seen its stock price take a beating...
Rarely in our nation’s history have political views been more polarized – or more toxic.
Political differences are inevitable, of course. But it’s a mistake to turn bullish or bearish on the market based on which party is in...
Editor’s Note: My friend Bryan Bottarelli, the Head Trade Tactician at Monument Traders Alliance, is one of the most knowledgeable and passionate traders I know.
In today’s guest article, he shares the biggest lesson he learned from his early...
Macy’s (NYSE: M) is one of America’s most iconic retailers – and one of my favorite places to shop. But lately, it’s been making headlines for its strategic transformation rather than its famous Thanksgiving Day parade.
The department store...
Politics have always been ugly. Even back in 1840, the campaign song “Tippecanoe and Tyler Too” praised the virtues of presidential candidate and eventual winner William Henry Harrison while calling incumbent president Martin Van Buren a “used-up man”...
Since Halloween is tomorrow, in this week’s Safety Net, we’re going to take a look at a dividend that many investors are afraid of.
For as long as I can remember, Wall Street has been scared silly about AbbVie...
